Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Receivables - Net (2016 - 2025)

Historic Receivables - Net for Healthstream (HSTM) over the last 16 years, with Q3 2025 value amounting to $27.7 million.

  • Healthstream's Receivables - Net rose 512.42% to $27.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.7 million, marking a year-over-year increase of 512.42%. This contributed to the annual value of $30.2 million for FY2024, which is 1210.33% down from last year.
  • As of Q3 2025, Healthstream's Receivables - Net stood at $27.7 million, which was up 512.42% from $26.9 million recorded in Q2 2025.
  • Over the past 5 years, Healthstream's Receivables - Net peaked at $41.6 million during Q1 2023, and registered a low of $26.3 million during Q3 2024.
  • Moreover, its 5-year median value for Receivables - Net was $30.3 million (2021), whereas its average is $31.6 million.
  • In the last 5 years, Healthstream's Receivables - Net tumbled by 2558.07% in 2021 and then surged by 2179.93% in 2023.
  • Quarter analysis of 5 years shows Healthstream's Receivables - Net stood at $30.3 million in 2021, then grew by 21.19% to $36.7 million in 2022, then fell by 6.49% to $34.3 million in 2023, then fell by 12.1% to $30.2 million in 2024, then dropped by 8.33% to $27.7 million in 2025.
  • Its Receivables - Net was $27.7 million in Q3 2025, compared to $26.9 million in Q2 2025 and $30.8 million in Q1 2025.